Dexcom (DXCM) Other Operating Expenses (2010 - 2022)

Dexcom (DXCM) has 6 years of Other Operating Expenses data on file, last reported at -$5.7 million in Q4 2022.

• Quarterly Other Operating Expenses fell 106.72% year-over-year to -$5.7 million in Q4 2022, while the trailing twelve-month figure through Sep 2023 was -$5.7 million (down 106.3% YoY) and the FY2021 annual result came in at $87.1 million, up 3384.0% from the prior year.
• Other Operating Expenses retreated to -$5.7 million in Q4 2022 per DXCM's latest filing, from $1.8 million in the prior quarter.
• Across five years, Other Operating Expenses topped out at $217.7 million in Q4 2018 and bottomed at -$5.7 million in Q4 2022.
• The 4-year median for Other Operating Expenses is $1.9 million (2022), against an average of $34.1 million.
• The widest annual swing landed in 2021, when Other Operating Expenses soared 3292.0%; it then sank 106.72% in 2022.
• Tracing DXCM's Other Operating Expenses over 4 years: stood at $217.7 million in 2018, then sank by 98.85% to $2.5 million in 2020, then soared by 3292.0% to $84.8 million in 2021, then slumped by 106.72% to -$5.7 million in 2022.
• Per Business Quant, the three latest DXCM Other Operating Expenses figures stand at -$5.7 million (Q4 2022), $1.8 million (Q3 2022), and $1.9 million (Q2 2022).

Peer Comparison